跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Nalbulin - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Nalbulin
Approved
STANDARD
Nalbulin
Global Pharmaceuticals
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
1256535ee0cb3bf2
Company
Global Pharmaceuticals
Type
Standard
Approval Details
Approval Id
1256535ee0cb3bf2
Drug Approval Philippines Name
Nalbulin
Product Name
Nalbulin
Registration Number
DR-XY41208
Brand Name
Nalbulin
Generic Name
Nalbuphine Hydrochloride
Dosage Form
Solution For Injection
Dosage Strength
10mg/mL
Manufacturer
Global Pharmaceuticals
Importer
Surestep Pharmaceuticals, Inc.
Distributor
Surestep Pharmaceuticals, Inc.
Company Detail Path
/organization/impax-laboratories-inc
Issuance Date
13 April 2022
Expiry Date
04 September 2027
Pharmacologic Category
Opioid Analgesic
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
1256535ee0cb3bf2
Type
Standard
Back to Philippines FDA Approvals